Vietnam AI in Drug Discovery Market Size, Share, Trends and Forecast by Offering, Application, Therapeutic Area, End User, and Region, 2025-2033

Vietnam AI in Drug Discovery Market Overview:

The Vietnam AI in drug discovery market size reached USD 7.50 Million in 2024. Looking forward, the market to reach USD 90.71 Million by 2033, exhibiting a growth rate (CAGR) of 28.31% during 2025-2033. The market is driven by accelerated AI integration in pharmaceutical research and development (R&D) processes, government policy support and infrastructure development initiatives, and enhanced clinical trial efficiency with significant cost reduction opportunities. These technological advancements and strategic investments are rapidly expanding the Vietnam AI in drug discovery market share.

Vietnam AI in Drug Discovery Market Trends:

Accelerated AI Integration in Pharmaceutical Research

Vietnamese pharmaceutical sector is undergoing a massive change with a faster adoption of AI in the research and development cycle. The trend is a radical change in the way in which drug discovery is handled, and artificial intelligence technologies are being implemented at different points throughout the pharmaceutical development cycle. The adoption of AI-driven solutions is enabling Vietnamese pharmaceutical companies and research institutions to analyze vast chemical libraries, predict molecular behavior, and identify promising drug candidates with unprecedented speed and accuracy. Machine learning algorithms are finding application in optimizing compound selection, drug-target interactions prediction, and automating the preclinical testing phase, which saves a major portion of time and resources used in developing early-stage drugs.

Government Policy Support and Infrastructure Development

The government in Vietnam has put in place extensive policy environments and infrastructure development programs to sustain the development of AI technologies across different industries, including drug research. The nation has put in place strong educational foundations and technological infrastructure to facilitate AI development across industries, which is also fueling the Vietnam AI in drug discovery market growth. This large human resource pool, along with government policies encouraging digital transformation and AI adoption, provides an inviting landscape for pharmaceutical firms to adopt AI-based drug discovery solutions. The National Innovation Center and other state-supported research centers are catalyzing partnerships between academic institutions and pharmaceutical firms, enabling knowledge transfers and speeding up the development of AI solutions in drug discovery.

Enhanced Clinical Trial Efficiency and Cost Reduction

Pharmaceutical research in Vietnam is being transformed to become more efficient and cost-effective through the introduction of AI technologies into clinical trials. Artificial intelligence solutions are in use to streamline the trial design, patient recruitment, and data analysis, and it has tremendously enhanced time-to-market and use of resources. These dramatic improvements are particularly valuable in Vietnam's developing pharmaceutical market, where cost efficiency and rapid development cycles are crucial for competitiveness. AI-powered patient stratification systems are enabling more precise participant selection, while predictive analytics are helping researchers anticipate potential trial outcomes and optimize study protocols. This enhanced efficiency is attracting both domestic and international pharmaceutical companies to consider Vietnam as a viable location for AI-enhanced clinical research activities.

Vietnam AI in Drug Discovery Market Segmentation:

The market provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels from 2025-2033. Our report has categorized the market based on offering, application, therapeutic area, and end user.

Offering Insights:

• Software
• Services

The report has provided a detailed breakup and analysis of the market by offering. This includes software and services.

Application Insights:

• Preclinical Testing
• Drug Optimization and Repurposing
• Target Identification
• Candidate Screening
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes preclinical testing, drug optimization and repurposing, target identification, candidate screening, and others.

Therapeutic Area Insights:

• Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Others

The report has provided a detailed breakup and analysis of the market by therapeutic area. This includes oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and others.

End User Insights:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Research Centers and Academic Institutes

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes pharmaceutical and biotechnology companies, contract research organizations (CROs), and research centers and academic institutes.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam AI in Drug Discovery Market Report Coverage:

Key Questions Answered in This Report:

• How has the Vietnam AI in drug discovery market performed so far and how will it perform in the coming years?
• What is the breakup of the Vietnam AI in drug discovery market on the basis of offering?
• What is the breakup of the Vietnam AI in drug discovery market on the basis of application?
• What is the breakup of the Vietnam AI in drug discovery market on the basis of therapeutic area?
• What is the breakup of the Vietnam AI in drug discovery market on the basis of end user?
• What is the breakup of the Vietnam AI in drug discovery market on the basis of region?
• What are the various stages in the value chain of the Vietnam AI in drug discovery market?
• What are the key driving factors and challenges in the Vietnam AI in drug discovery market?
• What is the structure of the Vietnam AI in drug discovery market and who are the key players?
• What is the degree of competition in the Vietnam AI in drug discovery market?

Key Benefits for Stakeholders:

• The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam AI in drug discovery market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam AI in drug discovery market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam AI in drug discovery industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.